Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ofer Merimsky
41 years of experience
accreditations :
Clinic is certified :
Carcinomatosis treatment cost in Israel typically involves specialized diagnostics like a histopathology revision which runs $500 to $800 and primary surgical interventions. A major procedure such as Hyperthermic Intraperitoneal Chemotherapy (HIPEC) ranges from $61,200 to $95,900. Total expenses depend on the clinical stage, length of hospitalization, and the hospital's public or private status. Patients often save between 30% and 80% compared to healthcare costs in the United States. Tel Aviv and Jerusalem are the primary medical hubs for these oncology services.
Typical Carcinomatosis Treatment Costs in Israel
Bookimed Expert Insight: For patients with digestive system cancers, specialized expertise in systemic and surgical treatments is vital. Sourasky Medical Center (Ichilov) features leading experts like Dr. Pelles Sharon, who trained at the Royal Marsden for gastrointestinal oncology. Patients seeking personalized care may prefer Assuta Medical Center, where they can personally select their attending physician. Sourasky reports a 90% oncology treatment success rate, offering high-value multidisciplinary care for over 400,000 annual patients.
| Israel | Turkey | Austria | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $61,200 | from $22,500 | from $40,000 |
Professor Ofer Merimsky brings over 41 years of experience of oncology experience, specializing in sarcoma and bone tumors at Sourasky Medical Center.
Dr. Pelles Sharon specializes in advanced cancer treatments, including HIPEC for carcinomatosis, at Sourasky Medical Center.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.